Published in J Exp Med on November 01, 1985
Clonal heterogeneity of synovial fluid T lymphocytes from patients with rheumatoid arthritis. Proc Natl Acad Sci U S A (1989) 1.25
Tolerogenic activity of polymerized type II collagen in preventing collagen-induced arthritis in rats. Clin Exp Immunol (1988) 0.97
Flare-up of experimental arthritis in mice with murine recombinant IL-1. Clin Exp Immunol (1992) 0.96
Activation pathways of synovial T lymphocytes. Expression and function of the UM4D4/CDw60 antigen. J Clin Invest (1990) 0.88
Partial characterization of a fibroblast-stimulating factor produced by cloned murine T lymphocytes. Am J Pathol (1988) 0.79
Immunotherapy of experimental arthritis. Analysis of the articular cartilage of mice suppressed for collagen-induced arthritis by a T-cell hybridoma. Am J Pathol (1987) 0.78
Immunotherapy of collagen-induced arthritis by a T-cell antiproliferative molecule. Am J Pathol (1990) 0.75
Protein measurement with the Folin phenol reagent. J Biol Chem (1951) 1743.91
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem (1976) 903.81
Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry (1965) 96.68
Silver staining of proteins in polyacrylamide gels. Anal Biochem (1981) 26.33
Autoimmunity to type II collagen an experimental model of arthritis. J Exp Med (1977) 10.09
Immunisation against heterologous type II collagen induces arthritis in mice. Nature (1980) 7.08
The rapid isolation of clonable antigen-specific T lymphocyte lines capable of mediating autoimmune encephalomyelitis. Eur J Immunol (1981) 3.96
Serum transfer of collagen-induced arthritis in mice. J Exp Med (1983) 3.74
Type II collagen-induced arthritis in rats. Passive transfer with serum and evidence that IgG anticollagen antibodies can cause arthritis. J Exp Med (1982) 3.06
Passive transfer by cells of type II collagen-induced arthritis in rats. J Clin Invest (1978) 2.81
Cellular sensitivity to collagen in rheumatoid arthritis. N Engl J Med (1978) 2.50
Collagen-induced arthritis in rats. Evaluation of early immunologic events. Arthritis Rheum (1979) 2.16
Isolation of albumin from whole human plasma and fractionation of albumin-depleted plasma. Biochem J (1976) 2.15
A new role for complement in experimental membranous nephropathy in rats. J Clin Invest (1980) 2.11
Evidence in support of a self-perpetuating HLA-DR-dependent delayed-type cell reaction in rheumatoid arthritis. Proc Natl Acad Sci U S A (1982) 1.99
Antigen-specific T lymphocyte clones. II. Purification and biological characterization of an antigen-specific suppressive protein synthesized by cloned T cells. J Exp Med (1981) 1.86
Experimental autoimmune encephalomyelitis (EAE) mediated by T cell lines: process of selection of lines and characterization of the cells. J Immunol (1982) 1.84
Morphologic demonstration of two stages in the development of type II collagen-induced arthritis. Lab Invest (1982) 1.47
Autoimmunity to collagen in adjuvant arthritis of rats. J Clin Invest (1980) 1.44
Type II collagen-induced arthritis. Studies with purified anticollagen immunoglobulin. Arthritis Rheum (1983) 1.42
Fine specificity of cloned insulin-specific T cell hybridomas: evidence supporting a role for tertiary conformation. J Immunol (1983) 1.33
Cell-mediated immunity to collagen and collagen alpha chains in rheumatoid arthritis and other rheumatic diseases. Am J Med (1980) 1.21
T cells produce an antigen-binding factor with in vivo activity analogous to IgE antibody. J Exp Med (1983) 1.14
Detection of autoimmune cells proliferating to myelin basic protein and selection of T cell lines that mediate experimental autoimmune encephalomyelitis (EAE) in mice. J Immunol (1983) 1.13
Lymphocytes induce resorption of cartilage by producing catabolin. Biochem J (1982) 1.11
Lymphokines in rheumatoid synovitis. Ann N Y Acad Sci (1975) 1.11
Antigen-specific suppression of collagen arthritis by adoptive transfer of spleen cells. Clin Immunol Immunopathol (1984) 1.10
Effect of psychological stress on the induction of arthritis in rats. Arthritis Rheum (1980) 1.08
Attenuation of an adjuvant arthritis by type II collagen. J Immunol (1983) 1.06
Experimental arthritis produced by injection of mediators of delayed hypersensitivity. Arthritis Rheum (1974) 1.03
Human interleukin 1 mediates cartilage matrix degradation. Cell Immunol (1985) 0.98
Effect of antithymocyte serum on collagen arthritis in rats: evidence that T cells are involved in its pathogenesis. Cell Immunol (1984) 0.89
A monoclonal antibody against antigen-specific helper factor augments T-cell help. Nature (1983) 0.88
Pretreatment of rats with anticollagen IgG renders them resistant to active type II collagen arthritis. Cell Immunol (1985) 0.84
Autoreactive rat T-cell lines: establishment and cellular characteristics. Cell Immunol (1984) 0.83
Collagens act as ligands to stimulate human monocytes to produce mononuclear cell factor (MCF) and prostaglandins (PGE2). Coll Relat Res (1982) 0.83
Rat leukocyte inhibitory factor (LIF): similarities to human LIF and generation by cells from rats with collagen-induced arthritis. Cell Immunol (1981) 0.82
Messenger RNA for an antigen-specific binding molecule from an antigen-specific T-cell hybrid. Proc Natl Acad Sci U S A (1984) 0.79
Native type II collagen-induced arthritis in the rat. III. Relationship between the cellular immune response to native type II collagen and arthritis. Ann Rheum Dis (1983) 0.79
Cell-mediated immunity in rats injected with an antimalaria T-cell line. Cell Immunol (1984) 0.77
Antigen-specific helper factor production by immortalized clone of OVA-specific T cells. I. In vitro activity. Cell Immunol (1984) 0.77
Strategies for medical treatment based on current understanding of the pathogenesis of rheumatoid arthritis. Clin Orthop Relat Res (1984) 0.77
Autoimmunity induced by type II collagen-coupled spleen cells. J Immunol (1981) 0.77
Autoimmunity to type II collagen an experimental model of arthritis. J Exp Med (1977) 10.09
Minocycline in rheumatoid arthritis. A 48-week, double-blind, placebo-controlled trial. MIRA Trial Group. Ann Intern Med (1995) 5.18
Oral tolerance: immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens. Annu Rev Immunol (1994) 4.07
Efficacy of low-dose methotrexate in rheumatoid arthritis. N Engl J Med (1985) 3.37
Humoral and cellular sensitivity to collagen in type II collagen-induced arthritis in rats. J Clin Invest (1978) 2.84
Passive transfer by cells of type II collagen-induced arthritis in rats. J Clin Invest (1978) 2.81
Cellular sensitivity to collagen in rheumatoid arthritis. N Engl J Med (1978) 2.50
Long-term prospective trial of low-dose methotrexate in rheumatoid arthritis. Arthritis Rheum (1988) 2.41
Collagen arthritis as a relevant model for rheumatoid arthritis. Arthritis Rheum (1982) 2.35
Angiogenesis inhibition suppresses collagen arthritis. J Exp Med (1992) 2.13
Association between bovine collagen dermal implants and a dermatomyositis or a polymyositis-like syndrome. Ann Intern Med (1993) 2.04
Treatment of rheumatoid arthritis with oral type II collagen. Results of a multicenter, double-blind, placebo-controlled trial. Arthritis Rheum (1998) 1.93
Pharmacokinetics, safety, and efficacy of combination treatment with methotrexate and leflunomide in patients with active rheumatoid arthritis. Arthritis Rheum (1999) 1.57
Synovial fluid tests. What should be ordered? JAMA (1990) 1.55
Morphologic demonstration of two stages in the development of type II collagen-induced arthritis. Lab Invest (1982) 1.47
Diversification of T cell responses to carboxy-terminal determinants within the 65-kD heat-shock protein is involved in regulation of autoimmune arthritis. J Exp Med (1997) 1.45
Autoimmunity to collagen in adjuvant arthritis of rats. J Clin Invest (1980) 1.44
Systemic lupus erythematosus: calciphylaxis induced cardiomyopathy. J Rheumatol (1995) 1.39
Antigen-specific suppression of type II collagen-induced arthritis by collagen-coupled spleen cells. J Immunol (1982) 1.25
Pathogenesis of rheumatoid arthritis. Lancet (1993) 1.25
Clinical and immunologic effects of fractionated total lymphoid irradiation in refractory rheumatoid arthritis. N Engl J Med (1981) 1.17
Dietary fish oil augments the induction of arthritis in rats immunized with type II collagen. J Immunol (1984) 1.14
Gold does not alter the arthritic, humoral, or cellular responses in rats with type II collagen-induced arthritis. Arthritis Rheum (1980) 1.12
Antigen-specific suppression of collagen arthritis by adoptive transfer of spleen cells. Clin Immunol Immunopathol (1984) 1.10
Suppression of collagen-induced arthritis by an angiogenesis inhibitor, AGM-1470, in combination with cyclosporin: reduction of vascular endothelial growth factor (VEGF). Cell Immunol (1995) 1.08
Augmentation of collagen arthritis by synthetic analogues of retinoic acid. J Immunol (1982) 1.08
A novel angiogenesis inhibitor suppresses rat adjuvant arthritis. Cell Immunol (1995) 1.08
Effect of psychological stress on the induction of arthritis in rats. Arthritis Rheum (1980) 1.08
Attenuation of an adjuvant arthritis by type II collagen. J Immunol (1983) 1.06
Systemic lupus erythematosus with a protein-losing enteropathy. JAMA (1976) 1.05
Autoimmunity to collagen: a shared feature of psoriatic and rheumatoid arthritis. Arthritis Rheum (1981) 1.05
Taxol involution of collagen-induced arthritis: ultrastructural correlation with the inhibition of synovitis and neovascularization. Clin Immunol Immunopathol (1998) 1.00
Suppression of collagen-induced arthritis using an angiogenesis inhibitor, AGM-1470, and a microtubule stabilizer, taxol. Cell Immunol (1994) 0.98
Treatment of stiff-man syndrome with intravenous immune globulin. Arthritis Rheum (1994) 0.97
A pilot trial of oral type II collagen in the treatment of juvenile rheumatoid arthritis. Arthritis Rheum (1996) 0.97
Polyneuropathy and anasarca: evidence for a new connective-tissue syndrome and vasculopathic contribution. Ann Intern Med (1976) 0.97
POEMS syndrome with myocardial infarction: observations concerning pathogenesis and review of the literature. Semin Arthritis Rheum (1992) 0.96
The effect of thalidomide and 2 analogs on collagen induced arthritis. J Rheumatol (1998) 0.96
Cyclosporin A treatment of refractory rheumatoid arthritis. Arthritis Rheum (1987) 0.95
Drug-induced lupus: an adjuvant disease? Am J Med (1981) 0.94
A cross sectional assessment of health status instruments in patients with rheumatoid arthritis participating in a clinical trial. Minocycline in Rheumatoid Arthritis Trial Group. J Rheumatol (1997) 0.94
Total lymphoid irradiation therapy in refractory rheumatoid arthritis. Fifteen- to forty-month followup. Arthritis Rheum (1984) 0.94
Systemic lupus erythematosus and concurrent cytomegalovirus vasculitis: diagnosis by antemortem skin biopsy. J Rheumatol (1989) 0.93
Altered immune response in adult women exposed to diethylstilbestrol in utero. Am J Obstet Gynecol (2001) 0.92
Type II collagen-induced auricular chondritis. Arthritis Rheum (1982) 0.92
Experimental synovitis induced by collagen-specific T cell lines. Cell Immunol (1989) 0.91
Arthritis with an inflammatory dermatosis resembling Sweet's syndrome. Report of a unique case and review of the literature on arthritis associated with the inflammatory dermatoses. Am J Med (1976) 0.91
Radiographic results from the Minocycline in Rheumatoid Arthritis (MIRA) Trial. J Rheumatol (1997) 0.90
Carpo:metacarpal ratio. A new quantitative measure of radiologic progression of wrist involvement in rheumatioid arthritis. Arthritis Rheum (1976) 0.90
HLA-DR4 is not a requisite for autoimmunity to collagen in rheumatoid arthritis. Arthritis Rheum (1984) 0.90
Modulation of human lymphocyte function by C3a and C3a(70-77). J Exp Med (1982) 0.89
Prevention of experimental autoimmune arthritis with a peptide fragment of type II collagen. Eur J Immunol (1993) 0.89
Effect of antithymocyte serum on collagen arthritis in rats: evidence that T cells are involved in its pathogenesis. Cell Immunol (1984) 0.89
Interleukin-2 diphtheria fusion protein (DAB486IL-2) in refractory rheumatoid arthritis. A double-blind, placebo-controlled trial with open-label extension. Arthritis Rheum (1995) 0.88
Transgenic mice expressing a truncated Peromyscus leucopus TNF-alpha gene manifest an arthritis resembling ankylosing spondylitis. J Interferon Cytokine Res (1998) 0.88
Environmental modulation of autoimmune arthritis involves the spontaneous microbial induction of T cell responses to regulatory determinants within heat shock protein 65. J Immunol (2001) 0.87
Activation of rat synovium by iron. Arthritis Rheum (1988) 0.86
Correlation between antibodies to type II collagen and treatment outcome in bilateral progressive sensorineural hearing loss. Lancet (1991) 0.86
Intractable vasculitis, resorptive osteolysis, and immunity to type I collagen in type VIII Ehlers-Danlos syndrome. Arthritis Rheum (1991) 0.86
Exacerbation of collagen arthritis by noise stress. J Rheumatol (1983) 0.86
Patterns of medication use before and after bone densitometry: factors associated with appropriate treatment. J Rheumatol (2000) 0.86
Intraarticular injection of arthritogenic factor causes mast cell degranulation, inflammation, fat necrosis, and synovial hyperplasia. Lab Invest (1988) 0.85
Rheumatoid arthritis: current clinical and research directions. J Womens Health (1997) 0.85
HLA-DRB1 genes and disease severity in rheumatoid arthritis. The MIRA Trial Group. Minocycline in Rheumatoid Arthritis. Arthritis Rheum (1996) 0.85
Connective tissue disease can develop in rats either spontaneously or after total lymphoid irradiation. J Rheumatol (1984) 0.85
The effect of minocycline in rat models of inflammatory arthritis: correlation of arthritis suppression with enhanced T cell calcium flux. Cell Immunol (1996) 0.85
Collagens stimulate the production of mononuclear cell factor (MCF) and prostaglandins (PGE2) by human monocytes. Trans Assoc Am Physicians (1980) 0.84
Collagen arthritis in the rat is initiated by CD4+ T cells and can be amplified by iron. Cell Immunol (1989) 0.84
Progress in the understanding of inducible models of chronic arthritis. Rheum Dis Clin North Am (1987) 0.84
Low dose penicillin for gonococcal arthritis. A comparative therapy trial. JAMA (1976) 0.83
Trichosporon cutaneum endocarditis: a sequela of intravenous drug abuse. Am J Clin Pathol (1982) 0.83
Total lymphoid irradiation in tertiary care for rheumatoid arthritis. Ann Intern Med (1985) 0.83
Collagens act as ligands to stimulate human monocytes to produce mononuclear cell factor (MCF) and prostaglandins (PGE2). Coll Relat Res (1982) 0.83
Model studies directed toward the application of boron neutron capture therapy to rheumatoid arthritis: boron delivery by liposomes in rat collagen-induced arthritis. Proc Natl Acad Sci U S A (1998) 0.83
Combination therapy in rheumatoid arthritis: the animal model perspective. J Rheumatol Suppl (1996) 0.82
Biochemical markers of disease activity. Baillieres Clin Rheumatol (1988) 0.82
Rat leukocyte inhibitory factor (LIF): similarities to human LIF and generation by cells from rats with collagen-induced arthritis. Cell Immunol (1981) 0.82
Suppressive effects of anti-mu serum on the development of collagen arthritis in rats. Clin Immunol Immunopathol (1984) 0.82
Attenuation of collagen arthritis and modulation of delayed-type hypersensitivity by type II collagen reactive T-cell lines. Cell Immunol (1987) 0.82
Cricoarytenoid synovitis in ankylosing spondylitis. Arthritis Rheum (1990) 0.81
Iron, iron-binding proteins and immune system cells. Ann N Y Acad Sci (1988) 0.81
Letter: Cause of adult toxic epidermal necrolysis. N Engl J Med (1975) 0.79
Taxol (paclitaxel) involution of articular cartilage destruction in collagen induced arthritis: an ultrastructural demonstration of an increased superficial chondroprotective layer. J Rheumatol (2000) 0.79
Anti-arthritic effects demonstrated by an interleukin-2 receptor-targeted cytotoxin (DAB486IL-2) in rat adjuvant arthritis. Eur J Immunol (1992) 0.79
The immunopathogenesis of rheumatoid arthritis. J Rheumatol Suppl (1985) 0.79
Potential of indium-111 to measure inflammatory arthritis. J Rheumatol (1986) 0.78
Wrist arthrography: review and comparison of normals, rheumatoid arthritis and gout patients. Semin Arthritis Rheum (1975) 0.78